Results 221 to 230 of about 1,566,141 (255)
The role of short-chain fatty acids in central nervous system diseases: A bibliometric and visualized analysis with future directions. [PDF]
HeliyonLan Z, Tang X, Lu M, Hu Z, Tang Z.
europepmc +1 more source
Intranasal administration of stem cell-derived exosomes for central nervous system diseases. [PDF]
Neural Regen ResGotoh S, Kawabori M, Fujimura M.
europepmc +1 more source
Positive Allosteric Modulators of alpha7 Nicotinic Acetylcholine Receptor for the Treatment of Several Central Nervous System Diseases. [PDF]
ACS Med Chem LettAbdel-Magid AF.
europepmc +1 more source
Central nervous system lyme disease [PDF]
Current Infectious Disease Reports, 2004 Nervous system infection with Borrelia burgdorferi frequently causes meningitis and rarely causes encephalomyelitis. Altered cognitive function also can occur in the absence of central nervous system infection. Recently developed serodiagnostic tools, such as the C6 assay, and appropriate use of Western blotting promise to improve diagnostic accuracy ...
openaire +4 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Inflammatory Diseases of the Central Nervous System
Neurologic Clinics, 2021Pediatric neuroinflammatory conditions are a complex group of disorders with a wide range of clinical presentations. Patients can present with a combination of focal neurologic deficits, encephalopathy, seizures, movement disorders, or psychiatric manifestations.
Eyal Muscal +2 more
openaire +3 more sources
Transglutaminase and diseases of the central nervous system
Frontiers in Bioscience, 2005Alzheimer's disease, Parkinson's disease and diseases of expanded polyglutamine are associated with insoluble protein aggregates and neuronal death. A role for transglutaminase in the stabilization of these aggregates has been proposed. Diseases of polyglutamine expansion have been the most thoroughly investigated and a large body of studies supports ...
Hoffner, Guylaine, Djian, Philippe
openaire +5 more sources
Amyloid in central nervous system disease
Clinical Neurology and Neurosurgery, 1990A review is presented of diseases of the central nervous system associated with amyloid deposition. The name amyloid is given to substances with particular physical characteristics which are independent of the chemical constitution of the proteins in the substance.
J. Haan, R.A.C. Roos
openaire +3 more sources
Central nervous system Lyme disease
Seminars in Pediatric Infectious Diseases, 2003Lyme disease is a disease caused by the spirochete, Borrelia burgdorferi. It is transmitted to humans via a bite from an infected tick. It has several classic stages or categories of illness, including early localized disease, early disseminated disease, and late disease.
Lucy Pontrelli, Sharon Nachman
openaire +3 more sources
Ergothioneine and central nervous system diseases
Neurochemical Research, 2022Ergothioneine (ERGO) is a thiol contained in the food that exhibits an excellent antioxidant effect similar to that of glutathione. Although mammals lack a biosynthetic pathway for ERGO, the carnitine/organic cation transporter OCTN1/SLC22A4, which transports ERGO in vivo, is expressed throughout the body, and ERGO is distributed to various organs ...
Noritaka Nakamichi +2 more
openaire +2 more sources